BioInvent International AB
STO:BINV
BioInvent International AB?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
17.12
50.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does BioInvent International AB hold over its rivals?
What risks and challenges
does BioInvent International AB face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of BioInvent International AB.
Provide an overview of the primary business activities
of BioInvent International AB.
What unique competitive advantages
does BioInvent International AB hold over its rivals?
What risks and challenges
does BioInvent International AB face in the near future?
Has there been any significant insider trading activity
in BioInvent International AB recently?
Summarize the latest earnings call
of BioInvent International AB.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for BioInvent International AB.
Provide P/S
for BioInvent International AB.
Provide P/E
for BioInvent International AB.
Provide P/OCF
for BioInvent International AB.
Provide P/FCFE
for BioInvent International AB.
Provide P/B
for BioInvent International AB.
Provide EV/S
for BioInvent International AB.
Provide EV/GP
for BioInvent International AB.
Provide EV/EBITDA
for BioInvent International AB.
Provide EV/EBIT
for BioInvent International AB.
Provide EV/OCF
for BioInvent International AB.
Provide EV/FCFF
for BioInvent International AB.
Provide EV/IC
for BioInvent International AB.
Show me price targets
for BioInvent International AB made by professional analysts.
What are the Revenue projections
for BioInvent International AB?
How accurate were the past Revenue estimates
for BioInvent International AB?
What are the Net Income projections
for BioInvent International AB?
How accurate were the past Net Income estimates
for BioInvent International AB?
What are the EPS projections
for BioInvent International AB?
How accurate were the past EPS estimates
for BioInvent International AB?
What are the EBIT projections
for BioInvent International AB?
How accurate were the past EBIT estimates
for BioInvent International AB?
Compare the revenue forecasts
for BioInvent International AB with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of BioInvent International AB and its key competitors using the latest financial data.
Compare historical revenue growth rates
of BioInvent International AB against its competitors.
Analyze the profit margins
(gross, operating, and net) of BioInvent International AB compared to its peers.
Compare the P/E ratios
of BioInvent International AB against its peers.
Discuss the investment returns and shareholder value creation
comparing BioInvent International AB with its peers.
Analyze the financial leverage
of BioInvent International AB compared to its main competitors.
Show all profitability ratios
for BioInvent International AB.
Provide ROE
for BioInvent International AB.
Provide ROA
for BioInvent International AB.
Provide ROIC
for BioInvent International AB.
Provide ROCE
for BioInvent International AB.
Provide Gross Margin
for BioInvent International AB.
Provide Operating Margin
for BioInvent International AB.
Provide Net Margin
for BioInvent International AB.
Provide FCF Margin
for BioInvent International AB.
Show all solvency ratios
for BioInvent International AB.
Provide D/E Ratio
for BioInvent International AB.
Provide D/A Ratio
for BioInvent International AB.
Provide Interest Coverage Ratio
for BioInvent International AB.
Provide Altman Z-Score Ratio
for BioInvent International AB.
Provide Quick Ratio
for BioInvent International AB.
Provide Current Ratio
for BioInvent International AB.
Provide Cash Ratio
for BioInvent International AB.
What is the historical Revenue growth
over the last 5 years for BioInvent International AB?
What is the historical Net Income growth
over the last 5 years for BioInvent International AB?
What is the current Free Cash Flow
of BioInvent International AB?
Discuss the annual earnings per share (EPS)
trend over the past five years for BioInvent International AB.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
SE |
B
|
BioInvent International AB
STO:BINV
|
1.9B SEK | 42.9 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 761 975.8 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
364.1B USD | 6.5 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
164.8B USD | 4.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
138.7B USD | 4.8 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.5B USD | 11.3 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 916.4 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
123.6B AUD | 5.1 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.6B USD | 4.8 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.5 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
32.5B EUR | 16 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
SE |
B
|
BioInvent International AB
STO:BINV
|
Average P/S:
3 342 182.4
42.9
|
134%
|
0.3 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 761 975.8
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.5
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
4.9
|
4%
|
1.2 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.8
|
3%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.3
|
10%
|
1.1 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 916.4
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
5.1
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
4.8
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.5
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16
|
37%
|
0.4 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.